Long-term survival in a patient with acinar cell carcinoma of pancreas. A case report and review of literature

Journal of the Pancreas

Volumn 8, Issue 6, 2007, Pages 783-789

  Antoine, Monique ^a,b   Khitrik Palchuk, Marina ^b   Saif, Muhammad Wasif ^b,c  

^a YALE CANCER CENTER   (United States)

^b GRIFFIN HOSPITAL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chromogranin A; Chymotrypsin; Gemcitabine; Pancreas; Pancreatic neoplasms; S 1 (combination); Somatostatin; Synaptophysin; Trypsin

Indexed keywords

CAPECITABINE; CHROMOGRANIN A; CHYMOTRYPSIN; CISPLATIN; DOCETAXEL; ERLOTINIB; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; OCTREOTIDE; OXALIPLATIN; PROTEIN KINASE C INHIBITOR; RAPAMYCIN; SUNITINIB; SYNAPTOPHYSIN; TRYPSIN;

ABDOMINAL TENDERNESS; ACINAR CELL CARCINOMA; ADULT; ANGIONEUROTIC EDEMA; ANOREXIA; ARTICLE; ASPIRATION BIOPSY; BLURRED VISION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; CHEST TIGHTNESS; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; COLITIS; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATALITY; FATIGUE; FEMALE; FEVER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LONG TERM CARE; MULTIPLE CYCLE TREATMENT; PANCREAS CARCINOMA; PANCREAS NECROSIS; PHARYNX DISEASE; PLEURA EFFUSION; SEPTIC SHOCK; SURVIVAL TIME; TUMOR CALCINOSIS; TUMOR DIFFERENTIATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, ACINAR CELL; FATAL OUTCOME; FEMALE; HUMANS; PANCREATIC NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 36749007649     PISSN: None     EISSN: 15908577     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Solcia, E, Capella C, Kloppel G. Tumors of the pancreas. In: Atlas of Tumor Pathology; 3rd Series, fascicle 20. Washington, DC, USA: AFIP, Armed Forces Institute of Pathology; 1997:103-14.
2. Sasatomi E, Krasinskas AM. A male in his 40s with a pancreatic mass (AP-0204). Final diagnosis: acinar cell carcinoma of the pancreas. Online case studies. University of Pittsburgh School of Medicine, Department of Pathology. Case 377 (Accessed November 22, 2006).
3. Handley ER, Schenker MP, Chang PS, Seltzer SE. Pancreatic acinar cell carcinoma. BrighamRAD Case Lists. Harvard Medical School, Department of Radiology, Brigham and Women's Hospital (Accessed November 22, 2006).
4. Aqel B, Scolapio J, Nguyen J, Krishna M, Raimondo M. Recurrent pancreatitis due to a cystic pancreatic tumor: a rare presentation of acinar cell carcinoma. JOP. J Pancreas (Online) 2004; 5:151-4.
5. American Cancer Society. Cancer Facts and Figures 2006. Atlanta, GA, USA: American Cancer Society, 2006.
6. Burroughs AK, Westaby D. Liver, biliary tract and pancreatic disease. In: Kumar P, Clark M, Eds. Clinical Medicine. 6th ed. London,UK: Elsevier Saunders Limited; 2005;406.
7. Ashley SW, Lauwers GY. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 37-2002. A 69-year old man with painful cutaneous nodules, elevated lipase levels, and abnomal resuls on abdominal scanning. N Engl J Med 2002; 347:1783-91.
8. Chiou YY, Chiang JH, Hwang JI, Yen CH, Tsay SH, Chang CY. Acinar cell carcinoma of the pancreas: clinical and computed tomography manifestations. J Comput Assist Tomogr 2004; 28:180-6.
9. Klimstra DS, Heffess CS, Oertel JE, Rosai J. Acinar cell carcinoma of the pancreas. A clinicopathological study of 28 cases. Am J Surg Pathol 1992; 16:815-37.
10. Matsuyama T, Ogata S, Sugiura Y, Yoshizumi Y, Aiko S, Aida S, Maehara T. Acinar cell carcinoma of the pancreas eroding the pylorus and duodenal bulb. J Hepatobiliary Pancreat Surg 2004; 11:276-9.
11. PAS-D glycogen digestion diastase. The Internet Pathology Laboratory for Medical Education (Accessed August 28, 2007).
12. Khalili M, Wax BN, Reed WP, Schuss A, Drexler S, Weston SR, Katz DS. Radiology-pathology conference. Acinar cell carcinoma of the pancreas. Clin Imaging-2006; 30:343-6.
13. Stelow EB, Bardales RH, Shami VM, Woon C, Presley A, Mallery S, et al. Cytology of pancreatic acinar cell carcinoma. Diagn Cytopathol 2006; 34:367-72.
14. NotoharaK, Hamazaki S, Tsukayma C, Nakamoto S, Kawabata K, Mizobuchi K, et al. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and Cd10. Am J Surg Pathol 2000; 24:1361-71.
15. Hoorens A, Lemoine NR, McLellan E, Morohoshi T, Kamisawa T, Heitz PU, et al. Pancreatic acinar cell carinoma. An analysis of cell lineage markers, p53 expression and Ki-ras mutation. Am J Pathol 1993; 143:685-98.
16. Cho KJ, Kim JY, Lee SS, Khang SK, Kim CW. Mixed acinar-endocrine carcinoma of the pancreas. A case report. J Korean Med Sci 1996; 11:188-192.
17. Pour PM, Pemert J, Mogaki M, Fuji H, Kazakoff K. Enodicrine aspects of exocrine cancer of the pancreas: their patterns and suggested biologic significance. Am J Clin Pathol 1993; 100: 223-30.
18. Chen CP, Chao Y, Li CP, Lee RC, Tsay SH, Chi KH, et al. Concurrent chemoradiation is effective in the treatment of alpha-fetoprotein-produin acinar cell carcinoma of the pancreas: report of a case. Pancreas 2001; 22:326-9.
19. Goldberg RM. Advances in the treatment of metastatic colorectal. cancer. Oncologist 2005; 10(Suppl 3):40-8.
20. Abraham S, Wu T, Hruban R, Lee JH, Yeo C, Conlon K, et al. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma. Frequent allelic loss on chromosome 11p and alterations in the APC/ beta-catenin pathway. Am J Pathol 2002; 160:953-62.
21. Riechelmann RP, Hoff PM, Moron RA, da Camera Lopes LH, Buzaid AC. Acinar cell carcinoma of the pancreas. Int J Gastrointestinal Cancer 2003; 34:67-712.
22. Defachelles AS, DeLassalle M, Boutard P, Nelken B, Schneider P, Patte C. Pancreatoblastoma in childhood: clinical course and therapeutic management of seven patients. Med Pediatr Oncol 2001; 37:47-52.
23. Murakami T, Ueki K, Kawakami H, Gondo T, Kuga t, Esato K, Furukawa S. Pancreatoblastoma: case report and review of treatment in the literature. Med Pediatr Oncol 1996; 27:193-7.
24. Shirasaka T, Tsukuda M, Inuyama Y, Taguchi T. New oral apticancer drug, TS-1 (S-1)-from bench to clnic. Gan To Kagaku Ryoho 2001; 28:855-64.
25. Harada K, Kawaguchi S, Supriatno Onoue T, Yoshida H, Sato M. Enhancement of apoptosis in salivary gland cancer cells by the combination of oral fluoropyrimidine anticancer agent (S-1) and radiation. Int J Oncol 2004; 25:905-11.
26. Ito D, Fujimoto K, Mori T, Kami K, Koizumi M, Toyoda E. et al. In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer. Int. J Cancer 2006; 118:2237-43.
27. Schwartz GK, Ward D, Saltz L, Casper ES, Spiess T, Mullen E, et al. A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin. Clin Cancer Res 1997; 3:537-43.
28. Lee JL, Kim TW, Chang HM, Lee SY, Kim MH, Kang YY, et al. Locally advanced acinar cell carcinoma of the pancreas successfully treated by capecitabine and concurrent radiotherapy: report of two cases. Pancreas 2003; 27:e18-22.